Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cypherpunk Technologies ( (CYPH) ) has issued an announcement.
Cypherpunk Technologies Inc. held a special meeting of stockholders on December 15, 2025, where several key proposals were approved. These included an increase in authorized shares, a reverse stock split, the adoption of the 2025 Equity Incentive Plan, and a private placement issuance proposal. Additionally, the company regained compliance with Nasdaq’s minimum bid price requirement as of December 11, 2025, after previously falling below the threshold.
The most recent analyst rating on (CYPH) stock is a Hold with a $1.25 price target. To see the full list of analyst forecasts on Cypherpunk Technologies stock, see the CYPH Stock Forecast page.
Spark’s Take on CYPH Stock
According to Spark, TipRanks’ AI Analyst, CYPH is a Underperform.
Leap Therapeutics faces significant financial challenges with persistent losses and no revenue growth, resulting in a low financial performance score. The technical analysis suggests bearish trends with some potential for short-term volatility. The company’s valuation metrics are also unfavorable due to negative earnings. No recent earnings call or corporate events data are available to impact the score further.
To see Spark’s full report on CYPH stock, click here.
More about Cypherpunk Technologies
Average Trading Volume: 25,681,489
Technical Sentiment Signal: Hold
Current Market Cap: $81.58M
See more data about CYPH stock on TipRanks’ Stock Analysis page.